Medical Developments International Limited
ASX:MVP.AX
0.455 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 33.149 | 32.337 | 21.943 | 25.272 | 22.535 | 20.876 | 17.461 | 18.347 | 15.471 | 11.608 | 9.37 | 11.733 | 11.313 | 10.206 | 8.296 | 8.727 | 9.219 | 7.396 | 6.605 | 5.404 | 3.048 | 5.475 |
| Cost of Revenue
| 8.783 | 34.853 | 25.003 | 8.598 | 8.797 | 6.692 | 5.097 | 5.764 | 4.26 | 3.554 | 3.05 | 3.402 | 3.467 | 3.669 | 2.992 | 3.031 | 3.495 | 2.507 | 2.235 | 1.926 | 1.04 | 0 |
| Gross Profit
| 24.366 | -2.516 | -3.06 | 16.674 | 13.738 | 14.184 | 12.364 | 12.583 | 11.211 | 8.054 | 6.32 | 8.331 | 7.846 | 6.537 | 5.304 | 5.696 | 5.724 | 4.889 | 4.37 | 3.478 | 2.008 | 5.475 |
| Gross Profit Ratio
| 0.735 | -0.078 | -0.139 | 0.66 | 0.61 | 0.679 | 0.708 | 0.686 | 0.725 | 0.694 | 0.674 | 0.71 | 0.694 | 0.641 | 0.639 | 0.653 | 0.621 | 0.661 | 0.662 | 0.644 | 0.659 | 1 |
| Reseach & Development Expenses
| 0 | 0.236 | 0.22 | 0.536 | 0.396 | 0.51 | 0.359 | 0.199 | 0.164 | 0.2 | 0.099 | 0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 32.545 | 32.578 | 22.212 | 15.23 | 4.321 | 4.135 | 3.99 | 3.696 | 3.559 | 2.03 | 1.742 | 1.369 | 1.685 | 1.686 | 1.663 | 2.116 | 1.507 | 1.242 | 1.29 | 1.531 | 0.8 | 0 |
| Selling & Marketing Expenses
| 2.822 | 3.825 | 2.596 | 1.308 | 5.382 | 4.269 | 4.437 | 3.7 | 2.537 | 1.752 | 2.076 | 2.12 | 1.624 | 1.514 | 1.048 | 1.013 | 1.508 | 1.027 | 0.979 | 0.672 | 0.224 | 0 |
| SG&A
| 35.367 | 17.757 | 12.635 | 21.377 | 11.469 | 9.673 | 9.327 | 8.005 | 6.637 | 4.178 | 4.208 | 3.823 | 3.309 | 3.2 | 2.711 | 3.129 | 3.015 | 2.269 | 2.269 | 2.203 | 1.024 | 0 |
| Other Expenses
| 5.866 | 19.097 | 0 | 0 | 0 | 0 | 0 | 1.901 | 1.098 | 0.111 | 0.025 | 0.041 | 0.181 | 0.123 | 0.05 | 0.1 | 0.05 | 0.071 | 0.007 | 0.007 | 0.004 | -3.133 |
| Operating Expenses
| 41.233 | 17.757 | 12.635 | 21.913 | 11.865 | 13.01 | 11.924 | 10.124 | 8.908 | 5.802 | 5.545 | 5.18 | 4.657 | 4.654 | 4.441 | 4.979 | 4.812 | 3.438 | 3.311 | 3.585 | 1.57 | 0.347 |
| Operating Income
| -16.867 | -20.273 | -15.695 | -5.239 | 1.873 | 3.173 | 2.069 | 3.501 | 3.556 | 2.932 | 1.71 | 3.778 | 3.189 | 1.883 | 0.863 | 0.717 | 0.912 | 1.515 | 1.059 | -0.107 | 0.438 | 5.128 |
| Operating Income Ratio
| -0.509 | -0.627 | -0.715 | -0.207 | 0.083 | 0.152 | 0.118 | 0.191 | 0.23 | 0.253 | 0.182 | 0.322 | 0.282 | 0.184 | 0.104 | 0.082 | 0.099 | 0.205 | 0.16 | -0.02 | 0.144 | 0.937 |
| Total Other Income Expenses Net
| -16.059 | 12.781 | -0.213 | -9.739 | -1.552 | -1.622 | -1.768 | -1.038 | -1.255 | -0.756 | -1.069 | -0.586 | 0.181 | 0.123 | 0.05 | 0.1 | 0.05 | 0.071 | 0.007 | 0.007 | 0.004 | -3.133 |
| Income Before Tax
| -32.926 | -7.492 | -15.908 | -14.978 | 0.321 | 1.551 | 0.301 | 2.463 | 2.301 | 2.176 | 0.641 | 3.192 | 3.789 | 2.495 | 1.273 | 1.175 | 1.301 | 1.703 | 1.159 | 0.358 | 0.688 | 1.995 |
| Income Before Tax Ratio
| -0.993 | -0.232 | -0.725 | -0.593 | 0.014 | 0.074 | 0.017 | 0.134 | 0.149 | 0.187 | 0.068 | 0.272 | 0.335 | 0.244 | 0.153 | 0.135 | 0.141 | 0.23 | 0.175 | 0.066 | 0.226 | 0.364 |
| Income Tax Expense
| 8.066 | -1.883 | -3.501 | -2.413 | -0.058 | 0.513 | 0.058 | 0.643 | 0.732 | 0.647 | 0.234 | 0.883 | 1.085 | 0.752 | 0.394 | 0.365 | 0.41 | 0.496 | 0.362 | 0.358 | 0.688 | 1.995 |
| Net Income
| -40.992 | -5.609 | -12.407 | -12.565 | 0.379 | 1.038 | 0.243 | 1.82 | 1.569 | 1.529 | 0.875 | 2.309 | 2.704 | 1.743 | 0.879 | 0.81 | 0.891 | 1.207 | 0.797 | 0.168 | 0.481 | 0 |
| Net Income Ratio
| -1.237 | -0.173 | -0.565 | -0.497 | 0.017 | 0.05 | 0.014 | 0.099 | 0.101 | 0.132 | 0.093 | 0.197 | 0.239 | 0.171 | 0.106 | 0.093 | 0.097 | 0.163 | 0.121 | 0.031 | 0.158 | 0 |
| EPS
| -0.46 | -0.067 | -0.17 | -0.18 | 0.006 | 0.016 | 0.004 | 0.031 | 0.027 | 0.027 | 0.015 | 0.041 | 0.05 | 0.034 | 0.017 | 0.015 | 0.016 | 0.021 | 0.014 | 0.003 | 0.011 | 0 |
| EPS Diluted
| -0.46 | -0.067 | -0.17 | -0.18 | 0.006 | 0.016 | 0.004 | 0.031 | 0.027 | 0.026 | 0.015 | 0.041 | 0.05 | 0.034 | 0.017 | 0.015 | 0.016 | 0.021 | 0.014 | 0.003 | 0.011 | 0 |
| EBITDA
| -29.446 | -17.16 | -12.75 | -1.49 | 4.47 | 4.362 | 2.865 | 3.985 | 3.944 | 3.206 | 1.969 | 4.009 | 3.436 | 2.25 | 1.626 | 1.545 | 1.625 | 2.051 | 1.572 | 1.13 | 1.138 | 5.475 |
| EBITDA Ratio
| -0.888 | -0.531 | -0.581 | -0.059 | 0.198 | 0.209 | 0.164 | 0.217 | 0.255 | 0.276 | 0.21 | 0.342 | 0.304 | 0.22 | 0.196 | 0.177 | 0.176 | 0.277 | 0.238 | 0.209 | 0.373 | 1 |